Tyrosinemia type III
Tyrosinemia type III | |
---|---|
Tyrosine | |
Classification and external resources | |
Specialty | endocrinology |
ICD-10 | E70.2 |
ICD-9-CM | 270.2 |
OMIM | 276710 |
DiseasesDB | 29836 |
eMedicine | ped/2339 |
MeSH | D020176 |
Type III tyrosinemia is a rare disorder caused by a deficiency of the enzyme 4-hydroxyphenylpyruvate dioxygenase (EC 1.13.11.27), encoded by the gene HPD. This enzyme is abundant in the liver, and smaller amounts are found in the kidneys. It is one of a series of enzymes needed to break down tyrosine. Specifically, 4-hydroxyphenylpyruvate dioxygenase converts a tyrosine byproduct called 4-hydroxyphenylpyruvate to homogentisic acid. Characteristic features of type III tyrosinemia include mild mental retardation, seizures, and periodic loss of balance and coordination (intermittent ataxia). Type III tyrosinemia is very rare; only a few cases have been reported.
This article is issued from Wikipedia - version of the 1/16/2015. The text is available under the Creative Commons Attribution/Share Alike but additional terms may apply for the media files.